Physician profile
Sameh Nassar
NPI 1629691845
$3,089.46
in general payments reported to CMS, 2019-2025
20 companies · $1,291 in 2025
The $1,291 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,201 · 2024: $598 · 2025: $1,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,852 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,851.98 |
| Education | $237.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $596.69 | 2023-2025 | Cardiomems, Ensite Precision, Ensite |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $551.32 | 2023-2025 | Lifevest |
| Boston Scientific Corporation | $294.17 | 2023-2025 | Watchman Flx |
| Novo Nordisk INC | $256.72 | 2023-2025 | Wegovy |
| Astrazeneca Pharmaceuticals Lp | $255.50 | 2023-2025 | Fasenra, Farxiga, Wainua |
| Abiomed | $166.24 | 2025 | |
| Genzyme Corporation | $141.50 | 2023 | |
| Itamar Medical INC | $114.62 | 2024 | Watchpatone |
| Bayer Healthcare Pharmaceuticals INC. | $104.52 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.40 | 2025 | Jardiance |
| Lantheus Medical Imaging, INC. | $85.32 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $78.55 | 2023 | |
| Merck Sharp & Dohme LLC | $70.14 | 2025 | Verquvo |
| Ge Healthcare | $66.66 | 2024 | |
| Pfizer INC. | $52.78 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $47.14 | 2025 | Onpattro |
| Teleflex LLC | $41.83 | 2024 | Manta |
| Novartis Pharmaceuticals Corporation | $29.19 | 2025 | |
| Getinge USA Sales, LLC | $24.38 | 2025 | Cardiosave Rescue |
| Bridgebio Pharma, INC. | $16.79 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Nassar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.